PAIONEERING
Table of contents:
| Trademark domain | |
| name | is free? |
|---|---|
| paioneering.com |  |
The "PAIONEERING" trademark, serial number 79028077 , was filed on 11th of May 2006 with a mark drawing code of 5000 and its transaction date is 79028077. The attorney assigned is Gary D. Krugman, attorney docket number S11796. Since 2nd of October 2010, the document can be found in the M60 law office in the publication and issue section. The employee responsible is LOWRY, LEIGH A and the date it was published for opposition on 11/04/2008. The status of this trademark was checked last on 08/12/2009.
Prior registrations: 2841852 , 3134824
Other trademarks by this attorney include , DYNAMIC COLLABORATION , AROCYTE . The corresponded responsible for this trademark is Gary D. Krugman, located at Sughrue Mion, PLLC, 2100 Pennsylvania Ave., NW, Washington, DC 20037-3213.The state or country where the trademark was organized is by Paion Deutschland Gmbh. The legal entity type behing it is a Other (Indicates Entity-Statement should appear)., located at Martinstr. 10-12, 52062 Aachen, zip .
| GOODS AND/OR SERVICES | |
| International Class - 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. | |
|---|---|
| U.S. Class | 046 - Foods and Ingredients of Foods |
| Class Status | 8 - Abandoned |
| Status Date | 08/12/2009 |
| Primary Code | 001 |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 8 - Abandoned |
| Status Date | 08/12/2009 |
| Primary Code | 005 |
| International Class - 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. | |
| U.S. Class | 044 - Dental, Medical, and Surgical Appliances |
| Class Status | 8 - Abandoned |
| Status Date | 08/12/2009 |
| Primary Code | 010 |
| International Class - 041 - Education; providing of training; entertainment; sporting and cultural activities. | |
| U.S. Class | 107 - Education and Entertainment |
| Class Status | 8 - Abandoned |
| Status Date | 08/12/2009 |
| Primary Code | 041 |
| International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 8 - Abandoned |
| Status Date | 08/12/2009 |
| Primary Code | 042 |
| Goods codes | |
| CC0000 | Color is not claimed as a feature of the mark. |
| GS0011 | Research reagents; biochemical preparations for scientific purposes |
| GS0051 | Pharmaceutical preparations, namely, pharmaceutical preparations derived from living organism proteins and peptides for treatment and diagnosis of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; pharmaceutical anti-inflammatory preparations; pharmaceutical nutraceutical preparations for the treatment of strokes, neuron damage, thrombotic diseases, tumors, cancer, heart disease including heart failure, circulation disorders, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; blood clotting test kits comprised of medical diagnostic reagents; medical and clinical diagnostic reagents for clinical or medical laboratory use; pharmaceutical preparations, namely, thrombolytic, fibrinolytic anti-coagulative, antithrombotical and neuroprotective substances for the treatment of blood clotting, cell protection and cell regeneration; products from biotechnological methods, namely, proteins for therapeutic and diagnostic use in the treatment and diagnosis of blood clotting disorders |
| GS0101 | Laboratory devices for medical and pharmaceutical investigations, namely, portable medical devices for conducting blood specimen analysis of the human blood clotting system and for conducting medical diagnostic tests in the nature of medical apparatus for diagnosing suspected heart attacks, strokes, thrombosis, circulations and vascular disorders, embolisms, kidney failures, liver damages, infections, viral infections, sepsis, inflammatory and neuronal disorders |
| GS0411 | Educational services, namely, providing seminars, educational exhibitions, correspondence courses, colloquiums, conferences, congresses, and workshops in the field of biotechnology, pharmacology, biochemistry, molecular biology, medical procedures, product research and development of medical devices and pharmaceutical preparations, research procedures, protein design diagnostics, molecular diagnostics, proteogenomic profiling, gendiagnostics |
| GS0421 | Database development for others; computer programming for others; performing chemical analyses for others; technical consultation in the field of biotechnology; services of a biotechnological laboratory, namely, conducting lab research for others in the field of drug research and development; pharmaceutical consulting, namely, performing pre-clinical studies, quality control; preparation of technical expert opinions in the field of chemical engineering, biology, molecular biology, pharmacology, chemistry, bio-technology, bio-chemistry, product research and development of medical devices and pharmaceutical preparations; and molecular diagnostic services of a bio-chemist, namely, product research and development services for others in the areas the treatment and diagnosis of stroke, neuron damage, thrombotic diseases, heart diseases including heart failure, circulation disorders, gene expression analysis, namely, protogenomic profiling, DNA-sequencing, drug target development and identifying, designing and analyzing therapeutic proteins, diagnostic services in the field of molecular science, comparative genome analysis, DNA-arrays including DNA-microarrays, creation of nucleic acid libraries, screening of nucleic acid libraries; performance of pre-clinical studies, namely, conducting and managing pre-clinical trials and studies of pharmaceutical, bio-technology and health care products; bio-chemical and biotechnological research and development for others, namely, bio-technical research and development regarding medical disease diagnosis and pharmacology, namely, prenatal diagnostic and identification of hereditary factors leading to diseases, identification of genes involved in the formation of cancer, identification of target molecules for cancer treatment, scientific research on and development of medical diagnostic equipment and pharmaceutical preparations and products for the treatment of tumors, cancer, dermatological diseases, spinal cord injuries, osteoporosis, cell degeneration, allergies, endocrine diseases, hormonal imbalances, nervous diseases, diseases of the respiration system, kidney and bladder diseases, infectious diseases, gastrointestinal diseases, pain and epilepsy; scientific and technical consulting for others in the field of medical science and drug research, namely, identifying, designing, and developing drugs, specifically, therapeutic proteins, gene expression analysis, namely, proteogenomic profiling, DNA-sequencing, drug target development, identification and design; medical science research services for others in the fields of prenatal diagnostics, molecular diagnostics, comparative genome analysis, DNA-arrays including DNA-microarrays, creating and screening of nucleic acid libraries, identifying hereditary factors leading to diseases, identifying genes involved in the formation of cancer, identification of target molecules for cancer treatment |
| PM0001 | PIONEERING |
| INTERNATIONAL REGISTRATION | |
| International Registration Number | 0896419 |
|---|---|
| International Registration Date | 05/11/2006 |
| International Publication Date | 11/02/2006 |
| International Renewal Date | 05/11/2016 |
| Auto protection | 04/12/2008 |
| International Status Code | 001 - Request for extension of protection established |
| International Status Date | 10/12/2006 |
| Priority Claimed In | Yes |
| Priority Claimed Date | 11/14/2005 |
| First Refusal In | Yes |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 05/06/2009 | OPPOSITION INSTITUTED NO. 999999 | T - TTAB Proceeding | OP.I - OPPOSITION INSTITUTED NO. 999999 | |
| 05/05/2009 | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | B | OPNS | |
| 05/05/2009 | OPPOSITION NOTICE (IB REFUSAL) CREATED | E | OPNC | |
| 01/15/2009 | OPPOSITION INSTITUTED NO. 999999 | T - TTAB Proceeding | OP.I - OPPOSITION INSTITUTED NO. 999999 | |
| 11/24/2008 | EXTENSION OF TIME TO OPPOSE RECEIVED | T - TTAB Proceeding | ETOF - EXTENSION OF TIME TO OPPOSE RECEIVED | |
| 07/18/2009 | REFUSAL PROCESSED BY IB | P | RFNT - REFUSAL PROCESSED BY IB | |
| 07/18/2009 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | P | OPNX - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | |
| 06/23/2009 | IRREGULARITY ON REFUSAL FROM IB | M | IRRF - IRREGULARITY ON REFUSAL FROM IB | |
| 09/19/2008 | EXAMINERS AMENDMENT -WRITTEN | R - Renewal | CNEA - EXAMINERS AMENDMENT -WRITTEN | |
| 09/19/2008 | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Z - Deletion | ZZZX - PREVIOUS ALLOWANCE COUNT WITHDRAWN | |
| 09/19/2008 | APPROVED FOR PUB - PRINCIPAL REGISTER | O - Outgoing Correspondence | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
| 08/11/2008 | ATTORNEY REVOKED AND/OR APPOINTED | I - Incoming Correspondence | ARAA - ATTORNEY REVOKED AND/OR APPOINTED | |
| 10/02/2010 | FINAL DECISION TRANSACTION PROCESSED BY IB | P | FINT - FINAL DECISION TRANSACTION PROCESSED BY IB | |
| 08/12/2010 | FINAL DISPOSITION NOTICE SENT TO IB | P | FICS - FINAL DISPOSITION NOTICE SENT TO IB | |
| 08/12/2010 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | P | FICR - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | |
| 12/01/2009 | OPPOSITION TERMINATED NO. 999999 | T - TTAB Proceeding | OP.T - OPPOSITION TERMINATED NO. 999999 | |
| 12/01/2009 | OPPOSITION DISMISSED NO. 999999 | T - TTAB Proceeding | OP.D - OPPOSITION DISMISSED NO. 999999 | |
| 08/12/2009 | ABANDONMENT NOTICE MAILED - AFTER INTER PARTES DECISION | O - Outgoing Correspondence | MAB4 - ABANDONMENT NOTICE MAILED - AFTER INTER PARTES DECISION | |
| 08/12/2009 | ABANDONMENT - AFTER INTER PARTES DECISION | O - Outgoing Correspondence | ABN4 - ABANDONMENT - AFTER INTER PARTES DECISION | |
| 08/12/2009 | OPPOSITION TERMINATED NO. 999999 | T - TTAB Proceeding | OP.T - OPPOSITION TERMINATED NO. 999999 | |
| 08/12/2009 | OPPOSITION SUSTAINED NO. 999999 | T - TTAB Proceeding | OP.S - OPPOSITION SUSTAINED NO. 999999 | |
| 11/04/2008 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
| 10/15/2008 | NOTICE OF PUBLICATION | O - Outgoing Correspondence | NPUB - NOTICE OF PUBLICATION | |
| 10/01/2008 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
| 09/19/2008 | APPROVED FOR PUB - PRINCIPAL REGISTER | O - Outgoing Correspondence | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
| 09/19/2008 | EXAMINER'S AMENDMENT ENTERED | I - Incoming Correspondence | XAEC - EXAMINER'S AMENDMENT ENTERED | |
| 09/19/2008 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | O - Outgoing Correspondence | GNEN | |
| 09/19/2008 | EXAMINERS AMENDMENT E-MAILED | O - Outgoing Correspondence | GNEA - EXAMINERS AMENDMENT E-MAILED | |
| 08/11/2008 | TEAS REVOKE/APPOINT ATTORNEY RECEIVED | I - Incoming Correspondence | REAP - TEAS REVOKE/APPOINT ATTORNEY RECEIVED | |
| 08/07/2008 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 08/07/2008 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 08/04/2008 | TEAS REQUEST FOR RECONSIDERATION RECEIVED | I - Incoming Correspondence | ERFR | |
| 08/04/2008 | ATTORNEY REVOKED AND/OR APPOINTED | I - Incoming Correspondence | ARAA - ATTORNEY REVOKED AND/OR APPOINTED | |
| 08/04/2008 | TEAS REVOKE/APPOINT ATTORNEY RECEIVED | I - Incoming Correspondence | REAP - TEAS REVOKE/APPOINT ATTORNEY RECEIVED | |
| 03/28/2008 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | P | OPNX - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | |
| 03/13/2008 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | P | OPNS - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | |
| 03/13/2008 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | P | OPNR - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | |
| 02/06/2008 | FINAL REFUSAL MAILED | O - Outgoing Correspondence | CNFR - FINAL REFUSAL MAILED | |
| 02/05/2008 | FINAL REFUSAL WRITTEN | R - Renewal | CNFR - FINAL REFUSAL WRITTEN | |
| 05/16/2007 | AMENDMENT FROM APPLICANT ENTERED | I - Incoming Correspondence | ACEC - AMENDMENT FROM APPLICANT ENTERED | |
| 05/16/2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 05/16/2007 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 04/23/2007 | PAPER RECEIVED | I - Incoming Correspondence | MAIL - PAPER RECEIVED | |
| 11/10/2006 | REFUSAL PROCESSED BY IB | P | RFNT - REFUSAL PROCESSED BY IB | |
| 10/24/2006 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | P | RFCS - REFUSAL SENT TO IB | |
| 10/24/2006 | REFUSAL PROCESSED BY MPU | P | RFRR | |
| 10/23/2006 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | E | RFCR - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | |
| 10/22/2006 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 10/13/2006 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 10/13/2006 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
| 10/12/2006 | SN ASSIGNED FOR SECT 66A APPL FROM IB | M | REPR - SN ASSIGNED FOR SECT 66A APPL FROM IB | |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.